Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Immucell Corp. (ICCC)

NASDAQ

$10.13

$+1.08

(+12.11%)

Immucell Corp. (ICCC) Live Price Chart

Page last updated: 2026-05-18 16:53:00

Key Market Data

Market Cap	$91.64M
Open	$9.05
High	$25.55
Low	$1.33
Previous Close	$8.92
Price Change	$+1.08
Percentage Change	+12.11%
Volume	80K

Immucell Corp. (ICCC) Stock Price Today

Immucell Corp. (ICCC) is currently trading at $10.13 as of 2026-05-18 16:53:00, reflecting a +12.11% move ($+1.08) from the previous close.

In the short term, the stock has returned +26.31% over the past four weeks. Over the last 12 months, Immucell Corp. has recorded a +84.85% price change, indicating a Strong performance relative to the broader market.

Immucell Corp. (ICCC) 7-Day Stock Price Changes

Over the past seven days, Immucell Corp. has traded within a short-term range shaped by market sentiment in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector. During this period, the stock moved from its previous closing price of $8.44 to the latest recorded price of $10.13, reflecting an intraday change of +12.11%. Daily movements highlight shifts in trading volume (80,239), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, ICCC has delivered a +26.31% return over the past month and a +84.85% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.

How to Buy Immucell Corp. (ICCC)

You can buy and trade ICCC on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for ICCC and Execute Your Trade

Open the trading page, enter ICCC in the search bar, select the amount of ICCC you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Immucell Corp. (ICCC)?

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Immucell Corp. Information

Industry	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees	73
Sector	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Company Website	https://www.immucell.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Immucell Corp.?

The latest trading price for Immucell Corp. (Common Stock) is $ 10.13, compared with a previous closing price of $ 8.92. That means the stock has moved +12.11% so far today. Intraday price updates and recent trading activity for ICCC can be tracked on the live chart and quote section on this page.

2.Is Immucell Corp. stock going up or down?

Looking at recent performances, ICCC has returned +26.31% over the past month, +120.22% over the last six months and +84.85% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Strong price momentum for Immucell Corp. stock, but keep in mind that past returns do not guarantee future results.

3.Where does ICCC currently sit relative to its 52-week high and low?

In the most recent 52-week period, Immucell Corp. has traded between a low of $ 4.52 and a high of $ 10.24. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether ICCC is currently nearer the top or the bottom of its one-year trading band.

4.How is Immucell Corp. classified by sector and industry?

Immucell Corp. is classified in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector. In practice, this means Immucell Corp. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing ICCC’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector could influence Immucell Corp.’s performance.

5.Where is Immucell Corp. listed and how large is it by market value?

Immucell Corp. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 91.64M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Immucell Corp.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does ICCC's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.06 summarises how much profit Immucell Corp. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Immucell Corp.'s financial performance over time?

To follow Immucell Corp.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how ICCC is performing and how the market is responding.

8.When is Immucell Corp. expected to report earnings?

Immucell Corp.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for ICCC, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Immucell Corp.'s earnings reports?

Immucell Corp.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether ICCC is meeting, beating or missing expectations.

10.How can I stay informed about Immucell Corp.'s results and guidance?

You can stay up to date on Immucell Corp. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for ICCC on this page helps you see how new information is being reflected in the stock.

11.Does Immucell Corp. pay a regular cash dividend to its shareholders?

Immucell Corp. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor ICCC's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for ICCC?

Based on the latest earnings data, ICCC has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Immucell Corp. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Immucell Corp. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Immucell Corp.?

Immucell Corp. is a publicly traded company in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry within the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is ICCC valued in terms of P/E ratio and EPS?

Immucell Corp. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.06. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Immucell Corp.'s earnings. Comparing ICCC's P/E and EPS to those of other IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Fossil Group, Inc.

FOSL

Hackett Group Inc (The).

HCKT

FIRST NATL CORP STRASBURG VA

FXNC

Oportun Financial Corporation

OPRT

Alector, Inc.

ALEC

Top Gainers

Browse today's leading gainers in the US stock market

Sunshine Biopharma Inc.

SBFM

Wellgistics Health, Inc.

WGRX

Virax Biolabs Group Limited

VRAX

GeoVax Labs, Inc. New

GOVX

Smart Powerr Corp.

CREG

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

ICCC-to-USD Calculator

Amount

ICCC

USD

1 ICCC = 10.13 USD